Abstract: The present invention relates to a power fetching system for a no neutral switch and a control method thereof, and a no neutral switch, wherein the power fetching system is connected to an electrical device and a wireless controller, and the wireless controller controls a switch module for changing an operating state of the electrical device.

Abstract: The present disclosure relates to PWM dimming circuit with low stand-by power. A lighting apparatus driver is provided, comprising: a power supplier to supply power to a lighting load; and a discrete PWM dimming circuit, the PWM dimming circuit is to receive PWM signal, and to control the switching of the power supplier based on the PWM signal, wherein the power supplier is capable of being turned off by the PWM dimming circuit.

Abstract: A method and apparatus for device finding after network configuration are disclosed. The method for device finding includes: sending a message to a smart device in an Access Point (AP) mode, the message comprising information for connecting to a first router or AP; changing connection from the smart device to a network; performing a local scanning when connecting to the first router or AP; and performing a cloud scanning when the local scanning fails.

Abstract: A presence sensing method for a light comprises detecting a presence of a user by a sensing module having a first sensitivity while the light is off; turning on the light when identifying the presence of the user and keeping the light on for a delay time period which has a preset length; increasing a sensitivity of the sensing module to a second sensitivity after turning on the light; detecting actions of the user by the sensing module having the second sensitivity while the light is on; determining a length of a next delay time period based on the actions of the user during the previous delay time period immediately prior to the next delay time period; and keeping the light on for the next delay time period.

Abstract: A presence sensing method for a light comprises detecting a presence of a user by a sensing module having a first sensitivity while the light is off; turning on the light when identifying the presence of the user and keeping the light on for a delay time period which has a preset length; increasing a sensitivity of the sensing module to a second sensitivity after turning on the light; detecting actions of the user by the sensing module having the second sensitivity while the light is on; determining a length of a next delay time period based on the actions of the user during the previous delay time period immediately prior to the next delay time period; and keeping the light on for the next delay time period.

Abstract: The present invention provides scaffolds that include a polymer and a cyclic peptide ligand. The peptide ligand increases the attachment of endothelial cells and/or progenitor cells to the scaffold. The present invention also provides engineered tissues that include the provided scaffolds. The present invention also provides coatings that include a coating polymer and a cyclic peptide ligand. The present invention also provides methods of improving endothelialization and vascularization of endothelial cells and/or progenitor cells for tissue regeneration in a subject and of repairing bone defects in a subject, by implanting a provided scaffold.

Abstract: The present specification discloses erythropoietin receptor agonists, compositions and medicaments comprising such erythropoietin receptor agonists, methods and uses for such erythropoietin receptor agonists and compositions and medicaments, and methods and uses for erythropoietin receptor agonists and compositions and medicaments for treating an anemia.

Abstract: The present specification discloses erythropoietin receptor agonists, compositions and medicaments comprising such erythropoietin receptor agonists, methods and uses for such erythropoietin receptor agonists and compositions and medicaments, and methods and uses for erythropoietin receptor agonists and compositions and medicaments for treating an anemia.

Abstract: Disclosed are methods and compositions for the detection, diagnosis, prognosis, and therapy of hematological malignancies, and in particular, B cell leukemias, lymphomas and multiple myelomas. Disclosed are compositions, methods and kits for eliciting immune and T cell responses to specific malignancy-related antigenic polypeptides and antigenic polypeptide fragments thereof in an animal. Also disclosed are compositions and methods for use in the identification of cells and biological samples containing one or more hematological malignancy-related compositions, and methods for the detection and diagnosis of such diseases and affected cell types. Also disclosed are diagnostic and therapeutic kits, as well as methods for the diagnosis, therapy and/or prevention of a variety of leukemias and lymphomas.

Abstract: The present invention relates to compositions and methods for immunotherapy of a subject afflicted with diseases such as cancer, an infectious disease, or a neurodegenerative disease, which methods comprise administering to the subject a composition comprising a therapeutically effective amount of an anti-PD-L1 antibody or portion thereof that potentiates an endogenous immune response, either stimulating the activation of the endogenous response or inhibiting the suppression of the endogenous response.

Abstract: Novel isolated stem cells derived from pre-term placental tissue and compositions comprising the stem cells are provided as well as use of the compositions for therapy, research and diagnosis. The cells and compositions are useful in treating Myelomeningocele (MCC), spina bifida (SB) or spinal cord injury or paralysis.

Abstract: The present invention relates to compositions and methods for immunotherapy of a subject afflicted with diseases such as cancer, an infectious disease, or a neurodegenerative disease, which methods comprise administering to the subject a composition comprising a therapeutically effective amount of an anti-PD-L1 antibody or portion thereof that potentiates an endogenous immune response, either stimulating the activation of the endogenous response or inhibiting the suppression of the endogenous response.

Abstract: This disclosure provides isolated cells and compositions comprising one or more isolated cell(s) as described herein. In one aspect, the isolated cell is a pre-term placenta-derived stem cell (also referred to placenta-derived multi potent stem cells (pmSCs). As used herein, the term “pre-term placenta-derived multipotent stem cell or placenta-derived stem cells” intends a cell isolated from placental tissue prior to delivery of the fetus by surgery or birth. In another aspect, the isolated cell is a chorionic villus (CV)-derived multipotent placental stem cells (C-mpSCs). Also provided are compositions comprising these cells, wherein the composition comprises an effective amount of the isolated cells as described herein.

Abstract: Provided herein is an isolated decelluarized amniotic membrane (DCM) and methods for using same therapeutically in vivo and in vitro. In one aspect, the isolated DCM is further processed, freezing, freeze drying, lyophilization micronized into powder or treatment with pepsin to create a hydrogel.

Abstract: Disclosed are methods and compositions for the detection, diagnosis, prognosis, and therapy of hematological malignancies, and in particular, B cell leukemias, lymphomas and multiple myelomas. Disclosed are compositions, methods and kits for eliciting immune and T cell responses to specific malignancy-related antigenic polypeptides and antigenic polypeptide fragments thereof in an animal. Also disclosed are compositions and methods for use in the identification of cells and biological samples containing one or more hematological malignancy-related compositions, and methods for the detection and diagnosis of such diseases and affected cell types. Also disclosed are diagnostic and therapeutic kits, as well as methods for the diagnosis, therapy and/or prevention of a variety of leukemias and lymphomas.

Abstract: The present invention relates to compositions and methods for immunotherapy of a subject afflicted with diseases such as cancer, an infectious disease, or a neurodegenerative disease, which methods comprise administering to the subject a composition comprising a therapeutically effective amount of an anti-PD-L1 antibody or portion thereof that potentiates an endogenous immune response, either stimulating the activation of the endogenous response or inhibiting the suppression of the endogenous response.

Abstract: A sutureless anastomosis device is provided herein comprising an outer tube defining an outer lumen and an inner tube formed of a compliant material defining an inner lumen. The inner tube is disposed within the outer lumen. In various embodiments, the anastomosis device is implanted such that proximal ends of the outer and inner tubes are secured around an outer surface of a proximal blood vessel, the distal end of the outer tube is secured to an outer surface of a distal blood vessel, and the distal end of the inner tube is secured to an inner surface of the distal blood vessel. Such a configuration connects the proximal blood vessel and distal blood vessel together in a manner that limits or eliminates turbulent flow through the anastomosis device. Methods of implantation are also disclosed.

Abstract: A container has a floor, bottom side beams are arranged to two sides of the floor, bottom cross beams are arranged between the bottom side beams on the two sides, at least the underside of the bottom cross beams is constructed as a closed structure, and/or at least the underside thereof extends only towards the ground. In the container, the underside of the bottom cross beams is free of a location where pests and microorganisms are hidden, thereby eliminating the potential of the pests and microorganisms being attached to the bottom cross beams and spreading everywhere with the container, and meanwhile the investigation of the container is also simplified, contributing to increasing the speed of circulation of containers.